14-day RSI
64.67
+3.03+4.92%
27 November 2024
Summary:
Monopar Therapeutics stock 14-day relative strength index is 64.67, with the most recent change of +3.03 (+4.92%) on 27 November 2024. According to this value, MNPR stock is neither oversold nor overboughtMNPR RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR RSI Performance
| PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
|---|---|---|---|---|
| todaytoday | +4.9% | +3.4% | +3.0% | +1.8% |
| 1 m1 month | +5.8% | +23.0% | +139.7% | +49.0% |
| 3 m3 months | +69.5% | +720.8% | +259.9% | +86.5% |
| 6 m6 months | +43.1% | +526.4% | +246.9% | +98.3% |
| ytdytd | +42.0% | +1058.8% | +521.5% | +36.9% |
| 1 y1 year | +89.8% | +1240.1% | +399.1% | -2.3% |
| 5 y5 years | - | - | - | - |
MNPR RSI High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 64.67 | at high | 57.07 | +13.3% |
| 3 m | 3 months | 93.57 | -30.9% | 35.33 | +83.0% |
| 6 m | 6 months | 93.57 | -30.9% | 23.42 | +176.1% |
| 1 y | 1 year | 93.57 | -30.9% | 23.42 | +176.1% |
| 3 y | 3 years | 93.57 | -30.9% | 19.88 | +225.3% |
| 5 y | 5 years | 93.57 | -30.9% | 4.39 | +1373.1% |
| alltime | all time | 93.57 | -30.9% | 4.39 | +1373.1% |
Monopar Therapeutics Stock RSI History
| Date | Value |
|---|---|
| 2024 | 64.67(+42.0%) |
| 2023 | 45.55(-3.6%) |
| 2022 | 47.23(+65.6%) |
| Date | Value |
|---|---|
| 2021 | 28.52(-47.8%) |
| 2020 | 54.64(+185.9%) |
| 2019 | 19.11 |
FAQ
- What is Monopar Therapeutics 14-day relative strength index?
- What is the all time high 14-day RSI for Monopar Therapeutics?
What is Monopar Therapeutics 14-day relative strength index?
The current 14-day RSI of MNPR is 64.67
What is the all time high 14-day RSI for Monopar Therapeutics?
Monopar Therapeutics all-time high 14-day relative strength index is 93.57